We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Delstrigo

News List

PIFELTRO, DELSTRIGO Receive FDA Approval for HIV-1 americanpharmaceuticalreview
September 23, 2019
Merck announced the U.S. Food and Drug Administration (FDA) approved supplemental New Drug Applications (sNDAs) for PIFELTRO™ (in combination with other antiretroviral agents) and DELSTRIGO™ ...
European Commission Approves Merck’s DELSTRIGO firstwordpharma
November 29, 2018
In the United States, both DELSTRIGO and PIFELTRO are indicated for the treatment of HIV-1 infection in adults with no prior antiretroviral treatment experience, and are administered orally once daily...
US approves MSD HIV drugs Delstrigo and Pifeltro pharmatimes
September 14, 2018
MSD’s HIV medicines Delstrigo and Pifeltro have been cleared by the US Food and Drug Administration for adult patients with no prior antiretroviral treatment experience.